about
Stability of a Tick-Borne Flavivirus in MilkLactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interactionThe Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical DiseasesLactoferrin from Milk: Nutraceutical and Pharmacological PropertiesTherapeutic and prevention strategies against human enterovirus 71 infectionAntimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsEarly experience with novel immunomodulators for cancer treatmentCattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrinMultiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1ß and lactoferrinInteraction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopes.HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrinImmunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornScreening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans.Lactoferrin protects against acetaminophen-induced liver injury in mice.Lactoferrin as a natural immune modulatorInhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.Effectiveness of esterified whey proteins fractions against Egyptian Lethal Avian Influenza A (H5N1)The airway epithelium: soldier in the fight against respiratory virusesLactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model.Genome-wide pathway analysis reveals different signaling pathways between secreted lactoferrin and intracellular delta-lactoferrin.Induction of lactoferrin gene expression in myeloid or mammary gland cells by human T-cell leukemia virus type 1 (HTLV-1) tax: implications for milk-borne transmission of HTLV-1.Heparan sulfate proteoglycan: an arbovirus attachment factor integral to mosquito salivary gland ducts.Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples.Human milk surveillance and research of environmental chemicals: concepts for consideration in interpreting and presenting study results.Proteomic identification of Syzygium cumini seed extracts by MALDI-TOF/MS.Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluidsBovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphateBovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptidesCationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma.Maternal milk contains antimicrobial factors that protect young rabbits from enteropathogenic Escherichia coli infectionLactotransferrin gene functional polymorphisms do not influence susceptibility to human immunodeficiency virus-1 mother-to-child transmission in different ethnic groups.Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission.A novel endo-β-N-acetylglucosaminidase releases specific N-glycans depending on different reaction conditionsTrichomoniasis and lactoferrin: future prospects.Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows.Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitroShort communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes.Oral mucosal immunity and HIV/SIV infection.
P2860
Q24456736-C836C216-E244-48C6-A2AA-7CEDEF4C2A24Q24556674-7D5D4BB3-CCBE-4C4C-B69A-35C1405B156AQ26797488-5F829945-3238-45D5-AF8D-B2E329C66312Q28077296-ADCCBD6D-671A-46ED-AFAC-B40FADE6D88EQ28080796-53C48F4C-97D3-4E1C-86FF-D462ABC2C725Q28087327-9D3541DE-9B1F-44E5-8C61-D84ED5D4D0E3Q28241744-B263C140-C9DD-457D-9F98-4B9803E14BD5Q28473868-ABD240E5-79D5-490C-8220-10E3699F141BQ28740326-11C01417-4FD4-4341-9AC4-C617657C72B9Q33247374-4BECB609-C431-4850-86C2-BBF8CD32D643Q33753950-7D3C0B61-6F23-4F4A-A6ED-F18781633A44Q33797110-EAF3BCED-95F7-43FD-B3FE-831AF624D192Q33835386-FEFA2FA5-3814-4F92-B4A6-CF98D5E60C0DQ33863096-61E012CA-AF22-49BB-A56C-FB1B5F03E6ACQ34009523-E9DD01CA-CD4D-4422-91C8-F2CE7E43300DQ34013719-B4CD3292-8721-4C38-B77D-43A3A9683A75Q34043199-7FE47FF6-14A4-45A2-83CC-62AB5CB9288FQ34259967-D98937D4-01B6-42CA-8DB8-AB7D8E12EF95Q34387936-1C792A58-24AB-479A-B8D3-308FC6848708Q34491598-BF9ADCB7-675C-4D05-AC65-C8659EB51C3DQ34537479-10D87B69-EDA2-431B-B2B0-8558A722578FQ34576428-ED9C3015-7012-4F18-9600-825B87EF267EQ34717839-B59D32E7-18DC-4C85-B70E-D0E80F35FC4CQ34774836-3D8CF314-D60E-40D6-B777-15548DD833B4Q34976381-DC65D962-CE09-4AF1-9608-4B57DD49AA31Q35019099-8C4DE34C-ED3A-465D-864D-5F38D9FF6620Q35066865-86E32AE2-5822-4967-B3B2-C3EDAC5C8861Q35075174-B5358E08-E2C7-4EC2-8F44-E32B27900E78Q35159976-C3374ED2-1FAD-44A5-8669-C2EFE9A3BD96Q35166195-CEA79171-F384-4C2B-9D56-D66EEF4D39B7Q35609521-8B201F0B-B960-4A9B-8854-566867D2D1B4Q35783582-D980357D-30B5-4332-B13B-C082145447FCQ35810674-189B98F7-7535-4909-B62F-7B9216A29B5CQ36062918-2BE24953-8BDC-4BB1-9D66-076364CB3C8CQ36217885-9FDF4F62-6ADB-4FE1-9B0C-F876E91B35BFQ36228684-52B9A2CF-9FBA-471B-9DB7-DD00972D7BDCQ36272874-FB5F7C6B-9F12-4A10-AEB3-04EA5C2E0BECQ36509605-878B0DD7-F650-489B-875B-088C7EC4507FQ36634965-EC81489A-5E25-4964-AD68-A6A58C82AD93Q36741771-0BDC0F05-9D68-4EFD-AC48-7259A90C1A58
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiviral activities of lactoferrin
@ast
Antiviral activities of lactoferrin
@en
Antiviral activities of lactoferrin
@en-gb
Antiviral activities of lactoferrin
@nl
type
label
Antiviral activities of lactoferrin
@ast
Antiviral activities of lactoferrin
@en
Antiviral activities of lactoferrin
@en-gb
Antiviral activities of lactoferrin
@nl
prefLabel
Antiviral activities of lactoferrin
@ast
Antiviral activities of lactoferrin
@en
Antiviral activities of lactoferrin
@en-gb
Antiviral activities of lactoferrin
@nl
P2093
P3181
P1433
P1476
Antiviral activities of lactoferrin
@en
P2093
B W van der Strate
D K Meijer
L Beljaars
M C Harmsen
P304
P3181
P356
10.1016/S0166-3542(01)00195-4
P407
P577
2001-12-01T00:00:00Z